Peptide Advocate
Back to News

/ Peptide Advocate

The 5 Most Common GLP-1 Side Effects (and How to Beat Them)

Nausea, diarrhea, constipation, vomiting, and indigestion are the most common GLP-1 side effects. They usually show up early, stay mild, and fade with time. Learn what to expect on Zepbound (tirzepatide) and Wegovy (semaglutide), and the simple fixes that help most people stay on track.

The 5 most common GLP-1 side effects, and how to beat them

Most GLP-1 side effects live in your gut, show up early, and fade with time. Here's what to expect, why it happens, and the simple fixes that help most people stay on track.

Peptide Advocate · Practical guide · Updated October 2026

Most commonNausea, followed by diarrhea, constipation, vomiting, and stomach pain or indigestion
When they show upMostly when you start, and in the weeks after each dose increase1,2
How badAbout 98% of stomach side effects in semaglutide trials were mild to moderate3
Who stays onMore than 95 in 100 trial participants did not stop treatment because of stomach side effects1,2

First, the good news

GLP-1 medicines such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are some of the most effective tools ever developed for weight and blood sugar. In the trials that led to their approval, most people lost at least 5% of their body weight, and the average person on the highest tirzepatide dose lost about 21%.6,7 Semaglutide also cut the risk of heart attack, stroke, or cardiovascular death by 20% in a large trial of people with heart disease and excess weight.2

Side effects are real, but they're usually the "getting used to it" kind. Knowing what's coming, and having a plan for it, makes a big difference.

85–91%of people on Zepbound lost at least 5% of their body weight in 72 weeks, depending on dose1
83.5%of people on Wegovy 2.4 mg lost at least 5% of their body weight in 68 weeks2
≤4.3%stopped treatment because of stomach side effects, even at the highest doses studied1,2
30–47%of people taking a placebo also reported stomach symptoms; some of what you feel is everyday life1,2

Why GLP-1s upset the stomach

GLP-1 medicines copy a natural gut hormone that tells your brain you've eaten and slows how fast food leaves your stomach. That's exactly how they help: smaller portions feel satisfying, and the feeling lasts. The flip side is that a too-big or too-rich meal can sit heavy, and your gut needs a few weeks to adjust each time the dose goes up.4

That's why every GLP-1 starts low and climbs slowly, usually one step every four weeks. Both the Zepbound and Wegovy labels say the slow climb is there to reduce stomach side effects, and that most nausea, vomiting, and diarrhea happen during these dose increases and then ease off.1,2

Side effects tend to flare after each dose step, then settle An illustrative chart. A green staircase shows the Zepbound dose rising from 2.5 mg to 15 mg every four weeks. A teal wave below rises briefly after each step and settles back down, with the bumps getting smaller over time. Side effects follow the dose steps Illustration based on the Zepbound starting schedule; Wegovy climbs in similar monthly steps Week 048121620 2.5 mg5 mg7.5 mg10 mg12.5 mg15 mg Weekly dose Typical stomach symptoms: a short flare after each step, then they settle
Not every step brings symptoms, and many people only notice mild queasiness. If a step is rough, prescribers can hold you at the current dose longer.1,2 Illustration: Peptide Advocate.

How common is each one?

Here are the five most common side effects as reported in the official prescribing information for the two leading weight-management GLP-1s.

How often the top five side effects were reported Percent of trial participants reporting each side effect. Nausea: Wegovy 44 percent versus 16 percent on placebo; Zepbound 15 mg 28 percent versus 8 percent. Diarrhea: Wegovy 30 versus 16; Zepbound 23 versus 8. Constipation: Wegovy 24 versus 11; Zepbound 11 versus 5. Vomiting: Wegovy 24 versus 6; Zepbound 13 versus 2. Stomach pain: Wegovy 20 versus 10; Zepbound 10 versus 5. Share of trial participants who reported it At any point during 68–72 weeks of treatment, with the placebo rate from the same trials Wegovy 2.4 mg (semaglutide) Zepbound 15 mg (tirzepatide) Nausea Diarrhea Constipation Vomiting Stomach pain 0%10%20%30%40% 44%28% 30%23% 24%11% 24%13% 20%10% placebo 16%placebo 8% placebo 16%placebo 8% placebo 11%placebo 5% placebo 6%placebo 2% placebo 10%placebo 5%
Sources: Wegovy and Zepbound prescribing information.1,2 These come from different trials, so the two drugs can't be compared head to head on this chart. Constipation on Zepbound was reported more at the 5 mg dose (17%) than at 15 mg.

Two things jump out. First, a good chunk of people on placebo reported the same symptoms, so the drug's true "extra" effect is smaller than the raw number. Second, most bouts are short. In the semaglutide trials, a typical episode of vomiting lasted about 2 days, diarrhea about 3, and nausea about 8. Constipation is the slow one, often hanging around for several weeks.3

How long a typical episode lasts Median length of a single episode with semaglutide 2.4 mg: vomiting 2 days, diarrhea 3 days, nausea 8 days, constipation 47 days. How long a typical episode lasts Median length of a single episode, semaglutide 2.4 mg (STEP 1–3 trials) VomitingDiarrheaNauseaConstipation 2 days3 days8 days47 days
Episodes can repeat, especially after a dose increase, but each one tends to be short. Constipation is the exception, so it pays to prevent it early.3
1

Nausea

The most common side effect, and usually the first to fade.

25–29%on Zepbound vs. 8% on placebo1
44%on Wegovy vs. 16% on placebo2

Nausea is the side effect of the same "I'm full" signal that makes these medicines work. Food stays in your stomach longer, so eating past the point of fullness, or eating something heavy, can leave you queasy. It's most noticeable in the first days after starting or stepping up a dose.

What helps

  • Eat smaller meals, slowly. Put the fork down between bites and stop at "satisfied," not "full." This is the single most useful habit.4,5
  • Go easy on greasy, fried, and very rich foods, especially in the first week after a dose increase.4
  • Keep bland, dry foods handy (crackers, toast, rice) for queasy moments.
  • Sip fluids between meals instead of drinking a lot with them, and don't lie down right after eating.
  • Try ginger or peppermint tea. The evidence is modest, but many people find them soothing.
  • Ask about pacing. Experts advise against moving to the next dose while you're still nauseous. Your prescriber can keep you at your current dose for longer, or prescribe a short-term anti-nausea medicine.2,5

Call your provider if nausea keeps you from eating or drinking for a day or more, or comes with severe belly pain.

2

Diarrhea

Common early on, but usually brief.

19–23%on Zepbound vs. 8% on placebo1
30%on Wegovy vs. 16% on placebo2

GLP-1s change how your gut moves and absorbs food, and some people get loose stools while their system adjusts. A typical episode lasts only a few days.3 The main thing to watch is fluids, because losing too much water is what turns a nuisance into a problem.

What helps

  • Hydrate on purpose. Water plus an electrolyte drink or broth replaces what you lose.1
  • Cut back on common triggers: greasy food, lots of caffeine, alcohol, and "sugar-free" products made with sugar alcohols like sorbitol.
  • Add soluble fiber such as oats, bananas, or psyllium, which helps firm things up.5
  • Check before using anti-diarrhea medicine. A pharmacist or prescriber can tell you if an over-the-counter option is a good fit.
  • Mention other medicines, especially metformin, which can also cause loose stools.

Call your provider if diarrhea lasts more than a couple of days, or you feel dizzy, are urinating much less, or have very dark urine. Dehydration can strain the kidneys.1

3

Constipation

Less dramatic, but the one most likely to linger, so get ahead of it.

11–17%on Zepbound vs. 5% on placebo1
24%on Wegovy vs. 11% on placebo2

A slower gut, plus eating and drinking less overall, can slow things down. Unlike nausea, constipation can stick around for weeks, which is why experts say it tends to outlast other stomach side effects.3,4 The good news: it responds well to simple, everyday habits.

What helps

  • Drink more than you think you need. A smaller appetite often means less thirst, too. Aim for pale-yellow urine.5
  • Build up fiber gradually with vegetables, berries, beans, whole grains, chia, or psyllium. Fiber works best with plenty of water.5
  • Move every day. A 10–15 minute walk after meals helps keep things moving.
  • Keep a routine and don't ignore the urge to go.
  • Ask a pharmacist about a gentle laxative or stool softener if lifestyle changes aren't enough.

Call your provider if you haven't had a bowel movement in several days and have severe belly pain, swelling, or vomiting. Rare cases of bowel blockage have been reported.1,2

4

Vomiting

Usually a sign of "too much, too fast," and usually over in a day or two.

8–13%on Zepbound vs. 2% on placebo1
24%on Wegovy vs. 6% on placebo2

Vomiting tends to happen when nausea builds, often after a meal that was bigger or richer than your new appetite can handle. In semaglutide trials, a typical episode lasted about two days.3 Many people find it becomes rare once they learn their new fullness cues.

What helps

  • Honor the "stop" signal. When you feel full, skip the last few bites. Your stomach is telling you the truth.4
  • Rest your stomach, then rehydrate slowly. After vomiting, take small, frequent sips of water, an oral rehydration drink, or broth before trying food.
  • Restart with bland foods like crackers, toast, rice, or applesauce.
  • Let your prescriber know. They may slow your dose increases or suggest an anti-nausea medicine.5

Call your provider if you can't keep fluids down for about a day, have signs of dehydration, or have severe pain along with vomiting.1

5

Stomach pain and indigestion

Includes bloating, burping, and heartburn. Mostly a "meal size" issue.

9–10%stomach pain on Zepbound vs. 5% on placebo; indigestion 9–10% vs. 4%1
20%stomach pain on Wegovy vs. 10% on placebo; indigestion 9% vs. 3%2

When food sits in the stomach longer, you may feel bloated, burp more, or notice heartburn, especially after big or fatty meals or right before bed. Both labels also list belching and reflux among the common side effects.1,2

What helps

  • Keep meals small and lower in fat. Heavy meals are the most common trigger.4
  • Skip fizzy drinks and eat slowly to swallow less air.
  • Finish eating 2–3 hours before bed, and raise the head of your bed if heartburn wakes you.
  • Ask a pharmacist about antacids. Many are fine, but some can interact with other medicines.

Call your provider right away if you have severe belly pain that won't go away, especially if it spreads to your back, or pain in the upper right belly with fever or yellowing skin. These can be signs of pancreatitis or a gallbladder problem.1,2

Quick reference

Side effectTry this firstGet help if
NauseaSmaller, slower meals; less greasy food; bland snacksYou can't eat or drink for a day
DiarrheaFluids and electrolytes; fewer triggers; soluble fiberIt lasts more than a couple of days, or you feel dizzy or dry
ConstipationMore water, more fiber, daily walksSeveral days without a bowel movement plus pain, swelling, or vomiting
VomitingStop at fullness; small sips to rehydrateYou can't keep fluids down
Stomach painSmall, lower-fat meals; no late eatingSevere or lasting pain, pain into the back, fever, or yellow skin

Why the benefits usually win

For most people who are good candidates, the math is encouraging. Stomach side effects are common, but they're typically mild, short-lived, and clustered in the first few months. In the major trials, only about 2 to 4 in 100 people stopped treatment because of them.1,2 Meanwhile, the benefits build over time: large, lasting weight loss, better blood sugar, lower blood pressure and triglycerides, and, for semaglutide, fewer heart attacks and strokes in people with heart disease.1,2

And in case you're wondering: the weight loss doesn't come from feeling sick. An analysis of the semaglutide trials found that stomach side effects explained very little of the weight people lost.3 The medicine works by quieting hunger, not by making you miserable.

Your best tool is your prescriber. Dose pacing is flexible. If a step is rough, it's normal and safe to ask about staying at your current dose longer or settling on a lower maintenance dose. Both labels allow for this.1,2 Pushing through severe symptoms isn't a badge of honor.

Less common, but important to know

  • Pancreatitis. Severe, persistent belly pain, sometimes spreading to the back, with or without vomiting. Stop the medicine and seek care.1,2
  • Gallbladder problems. Upper-right belly pain, fever, yellow skin or eyes, or clay-colored stools.1
  • Dehydration and kidney injury from ongoing vomiting or diarrhea.1,2
  • Severe stomach problems. These medicines aren't recommended for people with severe gastroparesis (a very slow-emptying stomach).1,2
  • Low blood sugar when combined with insulin or sulfonylureas.1,2
  • Thyroid tumors (boxed warning). Seen in rodents; whether this happens in humans is unknown. Don't use these medicines if you or a family member has had medullary thyroid cancer, or if you have MEN 2.1,2
  • Surgery and sedation. Tell your care team you take a GLP-1 before any procedure, because a slower stomach can affect anesthesia safety.1,2

The bottom line

Nausea, diarrhea, constipation, vomiting, and indigestion are the price of admission for many people starting a GLP-1, but for most it's a modest, temporary one. Eat smaller and slower, stay hydrated, keep fiber and movement in your day, and work with your prescriber on dose pacing. Do that, and most people get through the adjustment period and on to the results these medicines are known for.

References

  1. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information. U.S. FDA; revised February 2026. accessdata.fda.gov
  2. Novo Nordisk. Wegovy (semaglutide) prescribing information; revised June 2026. novo-pi.com
  3. Wharton S, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022. pmc.ncbi.nlm.nih.gov
  4. Wharton S, et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022;134(1):14–19. doi.org
  5. Gorgojo-Martínez JJ, et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2023;12(1):145. pmc.ncbi.nlm.nih.gov
  6. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205–216. pubmed.ncbi.nlm.nih.gov
  7. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989–1002. pubmed.ncbi.nlm.nih.gov

This article is for general education and is not medical advice. GLP-1 medicines are prescription drugs; talk with a licensed healthcare provider about whether one is right for you and before using any over-the-counter remedy for side effects. Information is current as of October 2026 and may change as new research and FDA decisions are published. Charts and illustrations are original works by Peptide Advocate.